{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:26:41Z","timestamp":1782602801899,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The treatment of choice for Extra-osseous Ewing\u2019s sarcoma\/primitive neuroectodermal tumor (ES\/PNET), a rare neoplasm, is the VAC\/IE regimen. This regimen includes Doxorubicin, Vincristine, Cyclophosphamide, Ifosfamide, and Etoposide, all of which have cardiotoxic effects. Myocarditis, a potentially threatening side effect following cancer therapy, can be accurately managed and diagnosed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case Presentation<\/jats:title>\n                <jats:p>In the current study, we report the case of a 19-year-old female with a mass on the abdominal wall, diagnosed with ES\/PNET. She was treated with the VAC\/IE regimen. A month after the last session of chemotherapy, she experienced dyspnea. Upon evaluation, a high level of troponin and a low left ventricular ejection fraction (LVEF) were detected via transthoracic echocardiography. She was treated with anti-heart failure drugs, but the response was unsatisfactory. The possibility of Cancer therapy-related myocarditis was suspected, and cardiac magnetic resonance imaging (CMR) confirmed acute myocarditis. This patient exhibited a significant response to intravenous immunoglobulin (IVIG), with her LVEF improving from 30\u201335%\u00a0to 50% within three months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this case, based on negative tests and the absence of viral signs and symptoms, Cancer therapy-related myocarditis is highly suspected as the cause of myocarditis. This case underscores the importance of accurately utilizing CMR as a non-invasive method for diagnosing myocarditis. It effectively highlights the identification of reversible myocarditis with appropriate treatment and the notable response to IVIG, suggesting its potential as a favorable treatment for myocarditis in younger patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-024-03960-6","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T07:02:13Z","timestamp":1718002933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis and management of cancer therapy-related myocarditis in a young female: A case report and review of literature"],"prefix":"10.1186","volume":"24","author":[{"given":"Amir hossein","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azin","family":"Alizadehasl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Shavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Firoozbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Meshgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Roudini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Dokhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"3960_CR1","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality."},{"key":"3960_CR2","doi-asserted-by":"crossref","unstructured":"Saif MW, Kaley K. Extraosseous Ewing\u2019s sarcoma of the pancreas: an uncommon but treatable disease. Cureus. 2017;9(11).","DOI":"10.7759\/cureus.1882"},{"issue":"1","key":"3960_CR3","doi-asserted-by":"publisher","first-page":"15656","DOI":"10.1038\/s41598-020-72680-6","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yuan Y, Zhang F, Hu K, Qiu J, Hou X, Yan J, Lian X, Sun S, Liu Z, Shen J. Outcome of multidisciplinary treatment of peripheral primitive neuroectodermal tumor. Sci Rep. 2020;10(1):15656.","journal-title":"Sci Rep"},{"key":"3960_CR4","doi-asserted-by":"crossref","unstructured":"Campbell K, Shulman D, Janeway KA, DuBois SG. Comparison of epidemiology, clinical features, and outcomes of patients with reported Ewing sarcoma and PNET over 40 years justifies current WHO classification and treatment approaches. Sarcoma. 2018;2018.","DOI":"10.1155\/2018\/1712964"},{"issue":"3","key":"3960_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.hoc.2005.03.004","volume":"19","author":"R Carvajal","year":"2005","unstructured":"Carvajal R, Meyers P. Ewing\u2019s sarcoma and primitive neuroectodermal family of tumors. Hematology\/Oncology Clin. 2005;19(3):501\u201325.","journal-title":"Hematology\/Oncology Clin"},{"issue":"2","key":"3960_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"C-H Pui","year":"2006","unstructured":"Pui C-H, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166\u201378.","journal-title":"N Engl J Med"},{"key":"3960_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12254-012-0014-3","volume":"5","author":"MJ van Den Bent","year":"2012","unstructured":"van Den Bent MJ, Snijders TJ, Bromberg JE. Current treatment of low grade gliomas. memo-Magazine Eur Med Oncol. 2012;5:223\u20137.","journal-title":"memo-Magazine Eur Med Oncol"},{"issue":"6","key":"3960_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/ctrv.2000.0175","volume":"26","author":"MT Meinardi","year":"2000","unstructured":"Meinardi MT, Gietema J, Van Veldhuisen D, Van der Graaf W, De Vries E, Sleijfer D. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev. 2000;26(6):429\u201347.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"3960_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/pbc.24404","volume":"60","author":"TR Brown","year":"2013","unstructured":"Brown TR, Vijarnsorn C, Potts J, Milner R, Sandor GG, Fryer C. Anthracycline induced cardiac toxicity in pediatric ewing sarcoma: a longitudinal study. Pediatr Blood Cancer. 2013;60(5):842\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"3960_CR10","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3389\/fphar.2018.01262","volume":"9","author":"CG Nebigil","year":"2018","unstructured":"Nebigil CG, D\u00e9saubry L. Updates in anthracycline-mediated cardiotoxicity. Front Pharmacol. 2018;9:1262.","journal-title":"Front Pharmacol"},{"key":"3960_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10741-020-09968-2","volume":"26","author":"Y Saleh","year":"2021","unstructured":"Saleh Y, Abdelkarim O, Herzallah K, Abela GS. Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment. Heart Fail Rev. 2021;26:1159\u201373.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"3960_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.36660\/abchf.20230009","volume":"2","author":"WD Martins","year":"2022","unstructured":"Martins WD, Schlabendorff E. Myocarditis in Cancer patients: a review of an emerging problem in Cardio-Oncology. ABC Heart Fail Cardiomyop. 2022;2(4):354\u201361.","journal-title":"ABC Heart Fail Cardiomyop"},{"issue":"6","key":"3960_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1517\/14740338.5.6.791","volume":"5","author":"RL Jones","year":"2006","unstructured":"Jones RL, Swanton C, Ewer MS. Anthracycline cardiotoxicity. Exp Opin Drug Saf. 2006;5(6):791\u2013809.","journal-title":"Exp Opin Drug Saf"},{"issue":"1","key":"3960_CR14","doi-asserted-by":"crossref","first-page":"232470961348034","DOI":"10.1177\/2324709613480346","volume":"1","author":"S Dhesi","year":"2013","unstructured":"Dhesi S, Chu MP, Blevins G, Paterson I, Larratt L, Oudit GY, et al. Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management. J Investig Med High Impact Case Rep. 2013;1(1):2324709613480346.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"3","key":"3960_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0749-0704(05)70196-2","volume":"17","author":"C Shanholtz","year":"2001","unstructured":"Shanholtz C. Acute life-threatening toxicity of cancer treatment. Crit Care Clin. 2001;17(3):483\u2013502.","journal-title":"Crit Care Clin"},{"issue":"3","key":"3960_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bmt.1703132","volume":"28","author":"P Morandi","year":"2001","unstructured":"Morandi P, Ruffini P, Benvenuto G, La Vecchia L, Mezzena G, Raimondi R. Serum cardiac troponin I levels and ECG\/Echo monitoring in breast cancer patients undergoing high-dose (7\u00a0g\/m2) cyclophosphamide. Bone Marrow Transplant. 2001;28(3):277\u201382.","journal-title":"Bone Marrow Transplant"},{"issue":"25","key":"3960_CR17","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","volume":"109","author":"ET Yeh","year":"2004","unstructured":"Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109(25):3122\u201331.","journal-title":"Circulation"},{"issue":"2","key":"3960_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0936-6555(05)80819-2","volume":"7","author":"C Airey","year":"1995","unstructured":"Airey C, Dodwell D, Joffe J, Jones W. Etoposide-related myocardial infarction. Clin Oncol. 1995;7(2):135.","journal-title":"Clin Oncol"},{"issue":"5","key":"3960_CR19","first-page":"887","volume":"59","author":"J Schecter","year":"1975","unstructured":"Schecter J, Jones S, Jackson R. Myocardial infarction in a 27-year-old woman: possible complication of treatemtn with VP-16-213 (NSC-141540), mediastinal irradiation, or both. Cancer Chemother Rep. 1975;59(5):887\u20138.","journal-title":"Cancer Chemother Rep"},{"key":"3960_CR20","doi-asserted-by":"publisher","first-page":"107362","DOI":"10.1016\/j.carpath.2021.107362","volume":"54","author":"F Piccirillo","year":"2021","unstructured":"Piccirillo F, Watanabe M, Di Sciascio G. Diagnosis, treatment and predictors of prognosis of myocarditis. A narrative review. Cardiovasc Pathol. 2021;54:107362.","journal-title":"Cardiovasc Pathol"},{"issue":"24","key":"3960_CR21","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"3960_CR22","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","volume":"23","author":"AR Lyon","year":"2022","unstructured":"17, Lyon AR, Lopez-Fernandez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart Journal-Cardiovascular Imaging. 2022;23(10):e333\u2013465.","journal-title":"Eur Heart Journal-Cardiovascular Imaging"},{"key":"3960_CR23","unstructured":"Leslie T, Cooper, Kirk U. Knowlton. Chapter 55, myocarditis. Braunwald\u2019s Heart Disease: A Textbook of Cardiovascular Medicine. 12th edition: Elsevier;2022."},{"issue":"2","key":"3960_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1536\/ihj.18-299","volume":"60","author":"X Huang","year":"2019","unstructured":"Huang X, Sun Y, Su G, Li Y, Shuai X. Intravenous immunoglobulin therapy for acute myocarditis in children and adults a meta-analysis. Int Heart J. 2019;60(2):359\u201365.","journal-title":"Int Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03960-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-03960-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-03960-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T07:03:27Z","timestamp":1718003007000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-03960-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3960"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-03960-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by Rajaie Cardiovascular, Medical and Research Center ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent were obtained from the patient\/legally authorized representative and\/or guardian\u2019s of all patients for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}